A Study to Determine the Effect of Food on OXN PR Tablet 80mg/40mg.
Research type
Research Study
Full title
An open-label, single-dose, 3-treatment, 3-period, randomised crossover study in healthy subjects to assess the pharmacokinetics of oxycodone and naloxone after administration of OXN PR tablet 80mg/40mg in a fed and fasted state, and oxycodone hydrochloride immediate release liquid 20mg (20mL of 5mg/5mL solution) and naloxone hydrochloride liquid 10mg (10mL of 1mg/1mL solution) in a fasted state.
IRAS ID
72242
Contact name
David J A Bell
Sponsor organisation
Mundipharma Research Limited
Eudract number
2010-023010-31
Research summary
This study is designed to determine the effect of food on the bioavailability of the combination study drug and to compare the PK and safety of the the study drug in tablet versus liquid format.
REC name
HSC REC B
REC reference
11/NI/0002
Date of REC Opinion
25 Feb 2011
REC opinion
Further Information Favourable Opinion